Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.
United European Gastroenterol J
; 9(1): 102-109, 2021 02.
Article
in En
| MEDLINE
| ID: mdl-33203342
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Colitis, Ulcerative
/
Tumor Necrosis Factor-alpha
/
Antibodies, Monoclonal
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
United European Gastroenterol J
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom